Skip to main content

Advertisement

Log in

Regional variability in changes in the incidence of hip fracture in the Spanish population (2000–2012)

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

The objective is to analyse the evolution of the incidence of hip fracture in the female population of Spain from 2000 to 2012 and to establish the possible changes which may have been seen over this period of time, including the trends in the different regions of the country.

Introduction

Fragility-related hip fractures are considered to be the fractures of greatest significance to public health due to their high degree of morbidity and mortality. The change in their incidence, both in absolute values and when adjusted for age, is the subject of debate. The objective of this article is to describe the changes in the rates of hip fracture in Spain by autonomous community between the years 2000 and 2012.

Methods

Using the data from the Spanish Minimum Basic Data Set, in which are all the recorded cases of women with a principal diagnosis of hip fracture, the incidence rates by age group and by autonomous community were obtained. Poisson distribution or negative binomial regressions were carried out to estimate the average annual change over the time period analysed.

Results

There have been statistically significant changes in the trends of rates of incidence for all age groups of women over 65 years of age. The annual reduction was 2.2 % for women of 65–74 years of age and less for those between 75 and 84. The rates of incidence for those over 85 increased annually by 0.58 %.

Conclusions

Hip fractures continue to increase in absolute numbers, although if the rates are adjusted for age, a downward trend is seen in certain age groups. These findings have various origins, although in the absence of great changes in population structure, we believe that drug treatments for osteoporosis may play a role. There is variability in the change in incidence of hip fractures in different parts of the country. Further studies are required to be able to identify the causes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22:465–475

    Article  PubMed  Google Scholar 

  2. Ivegard M, Svedbom A, Hernlund E, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Díez-Pérez A, Kanis JA (2013) Epidemiology and economic burden of osteoporosis in Spain. Arch Osteoporos 8(137):195–218

    Google Scholar 

  3. Auais M, Morin S, Nadeau L, Finch L, Mayo N (2013) Changes in frailty-related characteristics of the hip fracture population and their implications for healthcare services: evidence from Quebec, Canada. Osteoporos Int 24:2713–2724

    Article  CAS  PubMed  Google Scholar 

  4. Hernández JL, Olmos JM, Alonso MA, González-Fernández CR, Martínez J, Pajarón M, Llorca J, González-Macías J (2006) Trend in hip fracture epidemiology over a 14-year period in a Spanish population. Osteoporos Int 17:464–470

    Article  PubMed  Google Scholar 

  5. Leslie WD, O’Donell S, Jean S, Lagacé C, Walsh P, Bancej C, Morin S, Hanley DA, Papaoiannou A (2009) Trends in hip fracture rates in Canada. JAMA 302:883–889

    Article  CAS  PubMed  Google Scholar 

  6. Fisher AA, O’Brien ED, Davis MW (2009) Trends in hip fracture epidemiology in Australia: possible impact of biphosphonates and hormone replacement therapy. Bone 45:246–253

    Article  CAS  PubMed  Google Scholar 

  7. Chevalley T, Guilley E, Hermann FR, Hoffmeyer P, Rapin CH, Rizzoli R (2007) Incidence of hip fracture over a 10-year period (1991-2000): reversal of a secular trend. Bone 40:1284–1289

    Article  CAS  PubMed  Google Scholar 

  8. Jaglal SB, Weller I, Mamdani M, Hawker G, Kreder H, Jaakkimainen L, Adachi JD (2005) Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong? J Bone Miner Res 20:898–905

    Article  PubMed  Google Scholar 

  9. Azagra R, López-Expósito F, Martín-Sánchez JC, Aquyé A, Moreno N, Cooper C, Díez-Pérez A, Dennison EM (2014) Changing trends in the epidemiology of hip fractures in Spain. Osteoporos Int 25:1267–74

    Article  CAS  PubMed  Google Scholar 

  10. Etxebarria-Foronda I, Mar J, Arrospide A, Esnal-Baza E (2010) Trends in the incidence of hip fractures in women in the Basque country. Arch Osteoporos 5:131–137

    Article  Google Scholar 

  11. Melton LJ 3rd, Kanis JA, Johnell O (2005) Potential impact of osteoporosis treatment on hip fracture trends. J Bone Miner Res 20:895–897

    Article  PubMed  Google Scholar 

  12. Abrahamsen B, Vestergaard P (2010) Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997-2006. Osteoporos Int 21:373–380

    Article  CAS  PubMed  Google Scholar 

  13. Solomon DH, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Brookhart MA (2005) Compliance with osteoporosis medications. Arch Intern Med 165:2414–2419

    Article  PubMed  Google Scholar 

  14. Rossini M, Bianchi G, Di Munno O, Giannini S, Minisola S, Sinigaglia L, Adami S (2006) Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 17:914–921

    Article  CAS  PubMed  Google Scholar 

  15. Bernal-Delgado E, García Armesto S, Peiró S (2014) Atlas VPM group. Atlas of variations in medical practice in Spain: the Spanish National Health Service under scrutiny. Health Policy 114:15–30

    Article  PubMed  Google Scholar 

  16. Cameron AC, Trivedi PK (1988) Regression analysis of count data. Cambridge University Press, Cambridge

    Google Scholar 

  17. Dimai HP, Svedbom A, Fahrleitner-Pammer A, Pieber T, Resch H, Zwettler E, Chandran M, Borgström F (2011) Epidemiology of hip fractures in Austria: evidence for a change in the secular trend. Osteoporos Int 22:685–92

    Article  CAS  PubMed  Google Scholar 

  18. Richards M (2010) Extent and causes of international variations in drug usage. A report for the secretary of state for health by Professor Sir Mike Richards CBE. Central Office of Information, Londres

    Google Scholar 

  19. Guerra-García MM, Rodriguez-Fernández JB, Puga-Sarmiento E, Charle-Crespo MA, Gomes Carvalho CS, Prejigueiro-Santás A (2011) Incidence of hip fractures due to osteoporosis in relation to the prescription of drugs for their prevention and treatment in Galicia, Spain. Aten Primaria 43:82–8

    Article  PubMed  Google Scholar 

  20. Briongos L, Sañudo S, García-Alonso M, Ruiz-Mambrilla M, Dueñas-Laita A, Pérez-Castrillón JL (2013) Treatment of osteoporosis and hip fractures in a Spanish health area. Eur Rev Med Pharmacol Sci 17:266–8

    CAS  PubMed  Google Scholar 

  21. Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35:293–305

    Article  CAS  PubMed  Google Scholar 

  22. Imaz I, Zegarra P, González-Enriquez J, Rubio B, Alcazar R, Amate JM (2010) Poor biphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int 21:1943–51

    Article  CAS  PubMed  Google Scholar 

  23. de Felipe R, Cáceres C, Cimas M, Dávila G, Fernández S, Ruiz T (2010) Clinical characteristics of patients under treatment for osteoporosis in a primary care centre. Who do we treat? Aten Primaria 42:559–63

    Article  PubMed  Google Scholar 

  24. Lespessailles E, Cotté FE, Roux C, Fardellone P, Mercier F, Gaudin AF (2009) Incidence and features of osteoporosis in the French general population: the instant study. Joint Bone Spine 76:394–400

    Article  PubMed  Google Scholar 

  25. Cooper C, Eriksson JG, Forsén T, Osmond C, Tuomilehto J, Barker JP (2001) Maternal height, childhood growth and risk of hip fracture in later life: a longitudinal study. Osteoporos Int 12:623–629

    Article  CAS  PubMed  Google Scholar 

  26. Alonso-Franch M, Redondo Del Río MP, Suárez-Cortina L (2010) Nutrition and bone health in children. An Pediatr (Barc) 72:80.e1–11

    Article  CAS  Google Scholar 

  27. Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87:1080S–1086S

    CAS  PubMed  Google Scholar 

  28. Arana-Arri E, Gutiérrez-Ibarlucea I, Ecenarro-Mugaguren A, Asua-Batarrita J (2007) Incidence of certain osteoporosis-determinig habits among post-menopausal women in the Basque country, Spain, in 2003. Rev Esp Salud Publica 81:647–656

    Article  PubMed  Google Scholar 

  29. Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, Deng HW (2008) Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res 23:17–29

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA, Fujiwara S, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16:155–162

    Article  CAS  PubMed  Google Scholar 

  31. Nichols HB, Trentham-Dietz A, Hampton JM, Titus-Ernstoff L, Egan KM, Willet WC, Newcomb PA (2006) From menarche to menopause: trends among US women born from 1912 to 1969. Am J Epidemiol 164:1003–1011

    Article  PubMed  Google Scholar 

  32. Navarro-Valverde C, Quesada-Gómez JM (2014) Deficiencia de vitamina D en España. ¿Realidad o mito? Rev Osteoporos Metab Miner 6(Supl 1):S5–10

    Article  Google Scholar 

  33. García-Armesto S, Begoña Abadía-Taira M, Durán A, Hernández-Quevedo C, Bernal-Delgado E (2010) Spain: health system review. Health Syst Transit 12:1–295

    PubMed  Google Scholar 

  34. Prados-Torres A, Calderón-Larrañaga A, Hancco-Saavedra J, Poblador-Plou B, van den Akker M (2014) Multimorbidity patterns: a systematic review. J Clin Epidemiol 67:254–66

    Article  PubMed  Google Scholar 

  35. Mar J, Arrospide A, Comas M (2010) Budget impact analysis of thrombolysis for stroke in Spain: a discrete event simulation model. Value Health 13:69–76

    Article  PubMed  Google Scholar 

  36. Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF (2006) Risk of osteoporotic fracture in elderly patients taking warfarin. Results from the national registry of atrial Fibrilation 2. Arch Intern Med 166:241–246

    Article  CAS  PubMed  Google Scholar 

  37. Andress DL, Ozuna J, Tirschwell D, Grande L, Johnson M, Jacobson AF, Spain W (2002) Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol 59:781–786

    Article  PubMed  Google Scholar 

  38. Røste LS, Taubøll E (2007) Women and epilepsy: review and practical recommendations. Expert Rev Neurother 7:289–300

    Article  PubMed  Google Scholar 

  39. Salomon DH, Cadarette SM, Choudhry NK, Canning C, Levin R, Stürmer T (2009) A cohort study of thiazolidinediones and fractures in older adults with diabetes. J Clin Endocrinol Metab 94:2792–2798

    Article  Google Scholar 

  40. Zinman B, Haffner SM, Herman WH, Holman RR, Lachin JM, Kravitz BG, Paul G, Jones NP, Aftring RP, Viberti G, Kahn SE (2010) Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes. J Clin Endocrinol Metab 95:134–142

    Article  CAS  PubMed  Google Scholar 

  41. Yang YX, Lewis JD, Epstein S, Metz DC (2006) Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296:2947–2953

    Article  CAS  PubMed  Google Scholar 

  42. Khan MN, Khan AA (2008) Cancer treatment-related bone loss: a review and synthesis of the literature. Curr Oncol 15:S30–40

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  43. Warriner AH, Mugavero MJ (2010) Bone changes and fracture risk in individuals infected with HIV. Curr Rheumatol Rep 12:163–169

    Article  PubMed  Google Scholar 

  44. Olmos JM, Valero C, Del Barrio AG, Amado JA, Hernández JL, Menéndez-Arango J, González-Macías J (2010) Time course of bone loss in patients with anorexia nerviosa. Int Eat Disord 43:537–542

    Article  Google Scholar 

  45. Stein E, Ebeling P, Shane E (2007) Post-transplantation osteoporosis. Endocrinol Metab Clin North Am 36:937–963

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to acknowledge the editorial assistance provided by Andrew Stephens.

Conflicts of interest

Iñigo Etxebarria Foronda, Arantzazu Arróspide, Myrian Soto-Gordoa, José Ramón Caeiro, Luis Carlos Abecia and Javier Mar declare that they have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. Etxebarria-Foronda.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Etxebarria-Foronda, I., Arrospide, A., Soto-Gordoa, M. et al. Regional variability in changes in the incidence of hip fracture in the Spanish population (2000–2012). Osteoporos Int 26, 1491–1497 (2015). https://doi.org/10.1007/s00198-014-3015-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-014-3015-8

Keywords

Navigation